David C. Hohn - Concepedia

Concepedia

Author

David C. Hohn

The University of Texas MD Anderson Cancer Center

Also Known As

D C Hohn, D. C. Hohn, DAVID C. HOHN, David C. Hohn

29

Publications

1.7K

Citations

17

H-Index

63

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center University of California, San Francisco Cancer Research Institute

DC

About

David C. Hohn is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	1.4K
2	Health Sciences	6	6	742
3	Gastroenterology	2	2	120
4	Biochemistry	1	1	13
5	Cellular Physiology	1	1	199

David C. Hohn

×

20

Publications

1.7K

Citations

17

H-Index

	Year	Citations
A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. David C. Hohn, Robert Stagg, Michael Friedman, Journal of Clinical Oncology Colorectal Cancer MetastaticHepatologyGastrointestinal OncologyIa FudrLiver Physiology	1989	453
NADPH oxidase deficiency in X-linked chronic granulomatous disease. David C. Hohn, Robert I. Lehrer Journal of Clinical Investigation InflammationAutoimmune DiseaseNormal DonorsGranulocyteHematology	1975	250
Effect of O2 tension on microbicidal function of leukocytes in wounds and in vitro. David C. Hohn, R D MacKay, Betty J. Halliday, PubMed MechanobiologyInflammationO2 TensionGranulocyteMicrobicidal Function	1976	199
Chemoembolization for hepatocellular carcinoma. Alan P. Venook, Robert Stagg, B.J. Lewis, Journal of Clinical Oncology Hepatic DisordersHepatologyMedicineLiver PhysiologyHepatobiliary Tumor	1990	170
Alternating Hepatic Intra-Arterial Floxuridine and Fluorouracil: A Less Toxic Regimen for Treatment of Liver Metastases From Colorectal Cancer Robert Stagg, Alan P. Venook, Judy L. Chase, JNCI Journal of the National Cancer Institute	1991	98
Improved survival after resection of colorectal liver metastases George M. Fuhrman, Steven A. Curley, David C. Hohn, Annals of Surgical Oncology Surgical OncologyHepatologyColorectal Liver MetastasesColorectal SurgeryMedicine	1995	82
Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: Post‐treatment management and complications David H. Berger, C. Humberto Carrasco, David C. Hohn, Journal of Surgical Oncology	1995	77
Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: A phase I study Steven A. Curley, Robert A. Newman, Thomas B. Dougherty, Annals of Surgical Oncology Extracorporeal ChemofiltrationHepatologyHuman Hepatocellular CarcinomaMedicineLiver Physiology	1994	56
Management of inguinal lymph node metastases from adenocarcinoma of the rectum Roger A. Graham, David C. Hohn Diseases of the Colon & Rectum Surgical OncologyRectal AdenocarcinomaTumoral PathologyGastrointestinal OncologyColorectal Surgery	1990	41
Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity Bradley S. Davidson, Francesco Izzo, Judy L. Chase, The American Journal of Surgery Biliary ToxicityOncologyHepatologyColorectal Liver MetastasesMedicine	1996	38

Page 1